Stockdale Podiatry Group INC
Stockdale Podiatry Group INC was paid $27.55M by Medicaid between Jan 2018 and Dec 2024, across 91 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 14% of everything it billed.
33Billing provider infoSTOCKDALE PODIATRY GROUP INC
BAKERSFIELD, CA 93309
BAKERSFIELD, CA 93309
33aNPI1013013002assigned 09/16/2006
33bProvider typeFoot & Ankle Surgery Podiatrist
28Total paid$27.55M
24GClaims486,357
24DCodes billed91
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Foot & Ankle Surgery Podiatrist providers in California
Rank by total paid#2 of 384
Median peer was paid$24K
This provider vs. median1,150×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 39,157 | $1.22M | |
| 2019 | 46,636 | $1.64M | |
| 2020 | 55,685 | $2.56M | |
| 2021 | 71,824 | $3.45M | |
| 2022 | 62,278 | $3.93M | |
| 2023 | 90,656 | $5.85M | |
| 2024incomplete | 120,121 | $8.89M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 98,075 | 85,867 | $3.74M |
| Q4186 | Epifix, per square centimeter (add-on, list separately in addition to primary procedure) | 10% | 2,597 | 1,206 | $2.79M |
| 88381 | 9.0% | 27,479 | 16,933 | $2.47M | |
| 87799 | 8.3% | 16,693 | 16,581 | $2.29M | |
| 88312 | 6.1% | 17,926 | 17,709 | $1.69M | |
| G0452 | Molecular pathology procedure; physician interpretation and report | 5.6% | 14,847 | 14,661 | $1.53M |
| 11056 | 5.1% | 34,941 | 34,039 | $1.41M | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 4.4% | 17,916 | 17,702 | $1.21M |
| 97597 | 4.0% | 18,479 | 13,777 | $1.09M | |
| 20550 | 3.6% | 21,768 | 12,673 | $991K | |
| 88313 | 3.5% | 17,916 | 17,699 | $963K | |
| 11750 | 2.3% | 6,905 | 4,955 | $625K |
79 more codes
| 99243 | 2.1% | 8,695 | $582K | |
| 11721 | 1.9% | 23,645 | $513K | |
| 73630 | 1.8% | 22,761 | $503K | |
| 99204 | Doctor's office visit, new patient (more involved) | 1.8% | 4,788 | $489K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.5% | 4,776 | $413K |
| 97598 | 1.5% | 6,621 | $401K | |
| 11755 | 1.4% | 16,136 | $386K | |
| 28001 | 1.2% | 2,601 | $341K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1.2% | 981 | $333K |
| 15275 | 1.2% | 4,136 | $317K | |
| 99203 | Doctor's office visit, new patient (routine) | 1.1% | 5,370 | $308K |
| 29540 | 1.1% | 24,333 | $295K | |
| 11043 | <1% | 2,354 | $255K | |
| Q4187 | Epicord, per square centimeter (add-on, list separately in addition to primary procedure) | <1% | 39 | $223K |
| Q4131 | Epifix or epicord, per square centimeter | <1% | 539 | $156K |
| Q4278 | Epieffect, per square centimeter (add-on, list separately in addition to primary procedure) | <1% | 231 | $151K |
| 11057 | <1% | 6,166 | $123K | |
| Q4133 | Grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter (add-on, list separately in addition to primary procedure) | <1% | 28 | $106K |
| 29580 | <1% | 3,597 | $87K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 12,485 | $76K |
| 93925 | <1% | 856 | $71K | |
| 76882 | <1% | 6,280 | $68K | |
| 93970 | <1% | 705 | $64K | |
| 76942 | <1% | 1,872 | $55K | |
| G0127 | Trimming of dystrophic nails, any number | <1% | 4,899 | $51K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,576 | $51K |
| L3020 | Foot, insert, removable, molded to patient model, longitudinal/ metatarsal support, each | <1% | 300 | $39K |
| 11055 | <1% | 756 | $32K | |
| 87640 | <1% | 981 | $28K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 981 | $26K |
| 87653 | <1% | 981 | $25K | |
| 28003 | <1% | 42 | $19K | |
| 73610 | <1% | 890 | $16K | |
| 15004 | <1% | 287 | $16K | |
| 99223 | Prolong inpt eval add15 m | <1% | 187 | $15K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 1,420 | $14K |
| 17110 | <1% | 113 | $14K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,458 | $13K |
| 15271 | <1% | 160 | $12K | |
| 29581 | <1% | 404 | $10K | |
| 99242 | <1% | 259 | $8K | |
| 93922 | <1% | 143 | $8K | |
| 29799 | <1% | 211 | $5K | |
| 11307 | <1% | 135 | $5K | |
| 97760 | <1% | 109 | $4K | |
| A4580 | Cast supplies (e.g., plaster) | <1% | 63 | $3K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 261 | $3K |
| A5500 | For diabetics only, fitting (including follow-up), custom preparation and supply of off-the-shelf depth-inlay shoe manufactured to accommodate multi-density insert(s), per shoe | <1% | 74 | $3K |
| 99245 | <1% | 19 | $2K | |
| 73600 | <1% | 155 | $2K | |
| 1036F | <1% | 4,363 | $2K | |
| 29405 | <1% | 14 | $1K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 26 | $905.55 |
| 73700 | <1% | 14 | $811.99 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 135 | $659.94 |
| A5512 | For diabetics only, multiple density insert, direct formed, molded to foot after external heat source of 230 degrees fahrenheit or higher, total contact with patient's foot, including arch, base layer minimum of 1/4 inch material of shore a 35 durometer or 3/16 inch material of shore a 40 durometer (or higher), prefabricated, each | <1% | 48 | $651.14 |
| 99072 | <1% | 2,143 | $564.55 | |
| 11730 | <1% | 16 | $520.37 | |
| 95999 | <1% | 32 | $445.00 | |
| 73620 | <1% | 20 | $236.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 2,351 | $33.60 |
| 0518F | <1% | 1,154 | $32.16 | |
| 95851 | <1% | 31 | $20.80 | |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 38 | $11.19 |
| G9744 | Patient not eligible due to active diagnosis of hypertension | 0% | 308 | $0.00 |
| G8404 | Lower extremity neurological exam performed and documented | 0% | 431 | $0.00 |
| A6010 | Collagen based wound filler, dry form, sterile, per gram of collagen | 0% | 26 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 875 | $0.00 |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 12 | $0.00 |
| Q4177 | Floweramnioflo, 0.1 cc | 0% | 14 | $0.00 |
| 3288F | 0% | 47 | $0.00 | |
| G8410 | Footwear evaluation performed and documented | 0% | 385 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 216 | $0.00 |
| G8432 | Depression screening not documented, reason not given | 0% | 52 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 41 | $0.00 |
| 97610 | 0% | 95 | $0.00 | |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | 0% | 25 | $0.00 |
| G8950 | Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented | 0% | 30 | $0.00 |
| A6222 | Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHAWKINS, BRANDON (DOCTOR/OWNER)